SNYRQ · XBRL financial data

Synergy CHC financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (SNYRQ's year ends in late December)

In thousands of dollars	Q1 FY19Mar 31, 2019	Q2 FY19Jun 30, 2019	Q3 FY19Sep 30, 2019	Q4 FY19Dec 31, 2019	Q1 FY20Mar 31, 2020	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Revenue	—	—	—	—	—	7,126	10,271*	8,171	8,135	8,010	6,065*	5,493
Revenue from contracts with customers	9,469	6,337	7,365	6,187*	6,117	—	—	—	—	—	—	—
Cost of revenue	—	—	—	—	—	2,336	3,769*	2,007	1,896	2,329	3,846*	1,522
Cost of goods and services sold	2,540	1,608	2,490	2,499*	1,498	2,336	3,769*	—	—	—	—	—
Gross profit	6,929	4,729	4,874	3,688*	4,620	4,790	6,502*	6,164	6,239	5,681	2,219*	3,971
General and administrative	1,487	1,073	1,438	1,496*	1,334	1,197	1,268*	1,307	1,519	1,638	4,366*	2,049
Total operating expenses	5,105	4,024	4,511	14,536*	3,614	3,740	5,143*	4,216	4,615	4,401	15,530*	4,538
Operating income (loss)	1,823	705	363	(10,848)*	1,005	1,051	1,358*	1,948	1,624	1,280	(13,310)*	(567)
Interest income	—	—	—	—	—	—	year only	14	0	—	year only	0
Interest expense	—	—	—	—	—	378	57*	370	2,108	1,164	1,567*	2,012
Other income (expense)	362	347	—	—	—	—	year only	4,216	—	—	year only	4,538
Income tax expense (benefit)	(6)	40	(57)	(109)*	286	(192)	(12)*	(11)	190	(11)	(50)*	(14)
Net income (loss)	1,467	318	108	(11,101)*	262	784	106*	876	1,473	125	(14,816)*	(2,569)
Earnings per share, basic USD per share	0.02	0.00	0.00	(0.12)*	0.00	0.10	0.01*	0.10	0.17	0.01	—	(0.23)
Earnings per share, diluted USD per share	0.02	0.00	0.00	—	0.00	0.10	0.01*	0.10	0.17	0.01	—	(0.23)
Weighted average shares, basic thousands of shares	89,865	89,889	89,889	89,889*	89,889	7,554	8,046*	8,561	8,929	10,110	11,257*	11,304
Weighted average shares, diluted thousands of shares	89,865	89,889	89,889	—	89,899	7,554	8,215*	8,578	8,929	10,111	11,239*	11,304

Balance sheet

CSV

Fiscal quarters (SNYRQ's year ends in late December)

In thousands of dollars	Q1 FY19Mar 31, 2019	Q2 FY19Jun 30, 2019	Q3 FY19Sep 30, 2019	Q4 FY19Dec 31, 2019	Q1 FY20Mar 31, 2020	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Cash and cash equivalents	689	1,064	1,389	1,225	315	259	688	178	1,459	1,006	2,622	292
Accounts receivable	4,337	2,366	1,902	1,424	3,037	4,072	5,321	4,381	7,070	6,813	3,204	1,268
Inventory	2,668	2,492	2,233	1,861	1,714	1,911	1,717	2,346	2,364	2,146	3,738	3,382
Total current assets	8,671	7,033	6,464	5,047	5,358	11,853	16,060	15,406	19,510	20,508	10,014	6,345
Property and equipment, net	232	197	166	136	113	—	—	—	—	—	—	—
Goodwill	7,793	7,793	7,793	—	—	—	—	—	—	—	—	—
Total assets	19,435	17,493	16,623	5,191	5,477	12,170	16,343	15,656	19,726	20,691	10,164	6,462
Current portion of long-term debt	—	—	—	5,465	5,486	6,995	4,000	—	—	—	—	—
Total current liabilities	8,826	7,079	10,445	10,147	9,802	18,249	17,184	8,066	7,127	3,830	8,236	6,849
Long-term debt	—	—	—	—	—	—	7,457	10,897	24,979	25,113	25,056	25,018
Lease liability, non-current	—	—	—	—	—	—	8,333	—	—	—	—	—
Total liabilities	13,983	11,759	10,696	10,394	10,045	37,339	32,974	31,295	32,106	28,943	33,293	31,867
Accumulated deficit	(13,560)	(13,241)	(13,134)	(24,235)	(23,972)	(44,333)	(44,100)	(43,224)	(41,750)	(41,625)	(56,441)	(59,010)
Total stockholders' equity	5,452	5,734	5,928	(5,203)	(4,568)	(25,169)	(16,631)	(15,639)	(12,379)	(8,252)	(23,128)	(25,405)
Total liabilities and equity	19,435	17,493	16,623	5,191	5,477	12,170	16,343	15,656	19,726	20,691	10,164	6,462
Common shares outstanding (cover page) thousands of shares	89,889	89,889	89,889	89,889	89,889	8,704	8,752	9,014	9,442	11,252	11,304	14,900

Cash flows

CSV

Fiscal quarters (SNYRQ's year ends in late December)

In thousands of dollars	Q1 FY19Mar 31, 2019	Q2 FY19Jun 30, 2019	Q3 FY19Sep 30, 2019	Q4 FY19Dec 31, 2019	Q1 FY20Mar 31, 2020	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Net income (loss)	1,467	318	108	(11,101)*	262	784	106*	876	1,473	125	(14,816)*	(2,569)
Stock-based compensation	85	39*	39*	39*	39	5*	—	—	—	—	116*	116
Depreciation and amortization	—	—	—	—	—	—	33*	33	—	—	—	—
Net cash from operating activities	814	963*	754*	416*	(1,302)	(237)*	(3,426)*	(823)	(77)*	(2,309)*	624*	(2,045)
Proceeds from issuing common stock	—	—	—	—	—	—	year only	—	—	—	(161)*	2,673
Net cash from financing activities	(513)	(513)*	(513)*	(513)*	58	489*	3,908*	315	1,318*	1,883*	1,139*	(308)
Net change in cash	230	375*	288*	(165)*	(910)	172*	429*	(510)	1,281*	(452)*	1,616*	(2,330)

Compare with peers

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Synergy CHC	292	5,493	(2,045)	14.9M	0.1 quarters	Q1 FY26 10-QMar 31, 2026
Cellectar Biosciences	33,994	not reported	(6,010)*	9.5M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Earth Science Tech	631	9,026	707	287.6M	—	Q1 FY27 10-QJun 30, 2026
GeoVax Labs	3,143	not reported	(3,658)*	7.4M	0.9 quarters	Q2 FY26 10-QJun 30, 2026
Edesa Biotech	10,300	not reported	(3,083)*	9.6M	3.3 quarters	Q3 FY26 10-QJun 30, 2026
Cypherpunk Technologies	7,624	not reported	(2,692)*	107.8M	2.8 quarters	Q2 FY26 10-QJun 30, 2026
Cocrystal Pharma	2,169	105	(2,516)*	19.3M	0.9 quarters	Q2 FY26 10-QJun 30, 2026
Citius Pharmaceuticals	17,008	1,494	(8,678)*	27.5M	2.0 quarters	Q3 FY26 10-QJun 30, 2026
X4 Pharmaceuticals	195,095	2,400	(20,788)*	99.1M	9.4 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.